249 related articles for article (PubMed ID: 24343334)
1. Improving emotional face perception in autism with diuretic bumetanide: a proof-of-concept behavioral and functional brain imaging pilot study.
Hadjikhani N; Zürcher NR; Rogier O; Ruest T; Hippolyte L; Ben-Ari Y; Lemonnier E
Autism; 2015 Feb; 19(2):149-57. PubMed ID: 24343334
[TBL] [Abstract][Full Text] [Related]
2. Bumetanide for autism: more eye contact, less amygdala activation.
Hadjikhani N; Åsberg Johnels J; Lassalle A; Zürcher NR; Hippolyte L; Gillberg C; Lemonnier E; Ben-Ari Y
Sci Rep; 2018 Feb; 8(1):3602. PubMed ID: 29483603
[TBL] [Abstract][Full Text] [Related]
3. Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study.
van Andel DM; Sprengers JJ; Oranje B; Scheepers FE; Jansen FE; Bruining H
Mol Autism; 2020 May; 11(1):30. PubMed ID: 32381101
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial of bumetanide in the treatment of autism in children.
Lemonnier E; Degrez C; Phelep M; Tyzio R; Josse F; Grandgeorge M; Hadjikhani N; Ben-Ari Y
Transl Psychiatry; 2012 Dec; 2(12):e202. PubMed ID: 23233021
[TBL] [Abstract][Full Text] [Related]
5. NKCC1 Chloride Importer Antagonists Attenuate Many Neurological and Psychiatric Disorders.
Ben-Ari Y
Trends Neurosci; 2017 Sep; 40(9):536-554. PubMed ID: 28818303
[TBL] [Abstract][Full Text] [Related]
6. Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.
Lemonnier E; Villeneuve N; Sonie S; Serret S; Rosier A; Roue M; Brosset P; Viellard M; Bernoux D; Rondeau S; Thummler S; Ravel D; Ben-Ari Y
Transl Psychiatry; 2017 Mar; 7(3):e1056. PubMed ID: 28291262
[TBL] [Abstract][Full Text] [Related]
7. Judgments of auditory-visual affective congruence in adolescents with and without autism: a pilot study of a new task using fMRI.
Loveland KA; Steinberg JL; Pearson DA; Mansour R; Reddoch S
Percept Mot Skills; 2008 Oct; 107(2):557-75. PubMed ID: 19093617
[TBL] [Abstract][Full Text] [Related]
8. A Pilot Study on the Combination of Applied Behavior Analysis and Bumetanide Treatment for Children with Autism.
Du L; Shan L; Wang B; Li H; Xu Z; Staal WG; Jia F
J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):585-8. PubMed ID: 26258842
[TBL] [Abstract][Full Text] [Related]
9. Bumetanide to Treat Parkinson Disease: A Report of 4 Cases.
Damier P; Hammond C; Ben-Ari Y
Clin Neuropharmacol; 2016; 39(1):57-9. PubMed ID: 26757306
[TBL] [Abstract][Full Text] [Related]
10. Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1.
Kahle KT; Barnett SM; Sassower KC; Staley KJ
J Child Neurol; 2009 May; 24(5):572-6. PubMed ID: 19406757
[TBL] [Abstract][Full Text] [Related]
11. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model.
Dzhala VI; Brumback AC; Staley KJ
Ann Neurol; 2008 Feb; 63(2):222-35. PubMed ID: 17918265
[TBL] [Abstract][Full Text] [Related]
12. Bumetanide, a Diuretic That Can Help Children with Autism Spectrum Disorder.
Shaker E; El Agami O; Salamah A
CNS Neurol Disord Drug Targets; 2024; 23(4):536-542. PubMed ID: 37021422
[TBL] [Abstract][Full Text] [Related]
13. Bumetanide for autism: Open-label trial in six children.
Fernell E; Gustafsson P; Gillberg C
Acta Paediatr; 2021 May; 110(5):1548-1553. PubMed ID: 33336381
[TBL] [Abstract][Full Text] [Related]
14. Consequences of inhibition of bumetanide metabolism in rodents on brain penetration and effects of bumetanide in chronic models of epilepsy.
Töpfer M; Töllner K; Brandt C; Twele F; Bröer S; Löscher W
Eur J Neurosci; 2014 Feb; 39(4):673-87. PubMed ID: 24251546
[TBL] [Abstract][Full Text] [Related]
15. The functional neuroanatomy of social behaviour: changes in cerebral blood flow when people with autistic disorder process facial expressions.
Critchley HD; Daly EM; Bullmore ET; Williams SC; Van Amelsvoort T; Robertson DM; Rowe A; Phillips M; McAlonan G; Howlin P; Murphy DG
Brain; 2000 Nov; 123 ( Pt 11)():2203-12. PubMed ID: 11050021
[TBL] [Abstract][Full Text] [Related]
16. Serotonin and the neural processing of facial emotions in adults with autism: an fMRI study using acute tryptophan depletion.
Daly EM; Deeley Q; Ecker C; Craig M; Hallahan B; Murphy C; Johnston P; Spain D; Gillan N; Brammer M; Giampietro V; Lamar M; Page L; Toal F; Cleare A; Surguladze S; Murphy DG
Arch Gen Psychiatry; 2012 Oct; 69(10):1003-13. PubMed ID: 22638012
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin improves behavioural and neural deficits in inferring others' social emotions in autism.
Aoki Y; Yahata N; Watanabe T; Takano Y; Kawakubo Y; Kuwabara H; Iwashiro N; Natsubori T; Inoue H; Suga M; Takao H; Sasaki H; Gonoi W; Kunimatsu A; Kasai K; Yamasue H
Brain; 2014 Nov; 137(Pt 11):3073-86. PubMed ID: 25149412
[TBL] [Abstract][Full Text] [Related]
18. The GABA Polarity Shift and Bumetanide Treatment: Making Sense Requires Unbiased and Undogmatic Analysis.
Ben-Ari Y; Cherubini E
Cells; 2022 Jan; 11(3):. PubMed ID: 35159205
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical Benzodiazepine Response: A Rationale for Bumetanide in Neurodevelopmental Disorders?
Bruining H; Passtoors L; Goriounova N; Jansen F; Hakvoort B; de Jonge M; Poil SS
Pediatrics; 2015 Aug; 136(2):e539-43. PubMed ID: 26216321
[TBL] [Abstract][Full Text] [Related]
20. The functional correlates of face perception and recognition of emotional facial expressions as evidenced by fMRI.
Jehna M; Neuper C; Ischebeck A; Loitfelder M; Ropele S; Langkammer C; Ebner F; Fuchs S; Schmidt R; Fazekas F; Enzinger C
Brain Res; 2011 Jun; 1393():73-83. PubMed ID: 21513918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
